 Androgens effects erythropoietin treatment anemia end-stage renal disease androgens sensitivity erythroid progenitors present studies effect administration androgens actions exogenous erythropoietin EPO hemodialysis patients Studies group adult male hemodialysis patients Seven patients EPO dose IV times week additional group patients EPO times week mg nandrolone decanoate IM week weeks therapy hematocrit values group EPO contrast EPO combination nandrolone decanoate increase hematocrit values results groups low-dose EPO poor erythropoietic response contrast patients androgen addition EPO increase hematocrit values treatment Transfusions groups patients data androgen therapy action exogenous EPO doses EPO sufficient adequate hematopoietic response